دورية أكاديمية

IL-10 treatment decreases blood pressure in male, but not female, spontaneously hypertensive rats.

التفاصيل البيبلوغرافية
العنوان: IL-10 treatment decreases blood pressure in male, but not female, spontaneously hypertensive rats.
المؤلفون: Gillis EE; Department of Physiology, Augusta University, Augusta, Georgia., Musall JB; Department of Physiology, Augusta University, Augusta, Georgia., Baban B; Department of Oral Biology, Augusta University, Augusta, Georgia., Sullivan JC; Department of Physiology, Augusta University, Augusta, Georgia.
المصدر: American journal of physiology. Renal physiology [Am J Physiol Renal Physiol] 2020 Sep 01; Vol. 319 (3), pp. F359-F365. Date of Electronic Publication: 2020 Jul 20.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901990 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-1466 (Electronic) Linking ISSN: 15221466 NLM ISO Abbreviation: Am J Physiol Renal Physiol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Bethesda, Md. : American Physiological Society, c1997-
مواضيع طبية MeSH: Blood Pressure/*drug effects , Interleukin-10/*pharmacology, Animals ; Female ; Gene Expression Regulation/drug effects ; Inflammation/metabolism ; Infusion Pumps ; Infusions, Subcutaneous ; Interleukin-10/administration & dosage ; Kidney/cytology ; Kidney/drug effects ; Kidney/metabolism ; Male ; Nitric Oxide Synthase/genetics ; Nitric Oxide Synthase/metabolism ; Random Allocation ; Rats ; Rats, Inbred SHR ; Receptors, Interleukin-10/genetics ; Receptors, Interleukin-10/metabolism ; Sex Factors ; T-Lymphocytes/cytology
مستخلص: Interleukin-10 (IL-10) is an anti-inflammatory cytokine that induces nitric oxide (NO) production. IL-10 supplementation has been previously shown to lower blood pressure (BP) in male hypertensive mice, but the effect of exogenous IL-10 in hypertensive female rodents has not been studied. For the present study, we hypothesized that chronic infusion of IL-10 in hypertensive rats would lower BP concomitant with an increase in renal NO synthase (NOS) activity. Male and female spontaneously hypertensive rats (SHRs; 12 wk old) were randomized to receive IL-10 infusion by subcutaneous minipump (3.5 µg·kg -1 ·day -1 ) or serve as sham controls ( n = 4-6 rats per treatment per sex). BP was measured by tail cuff before and after 2 wk of treatment. Renal T cells and IL-10 were measured by flow cytometry, and NOS activity was determined by conversion of radiolabeled arginine to radiolabeled citrulline. Female SHRs had greater IL-10 + renal cells than male SHRs and greater expression of the IL-10 receptor at baseline. BP did not change in female SHRs treated with IL-10, but BP significantly decreased following IL-10 infusion in male SHRs. Contrary to our hypothesis, NOS enzymatic activity decreased with IL-10 treatment in the renal inner medulla and cortex of both sexes. Renal regulatory T cells also decreased in both sexes after IL-10 treatment. In conclusion, despite male SHRs having less IL-10 and IL-10 receptor expression in the kidney compared with female SHRs, exogenous IL-10 selectively decreased BP only in male SHRs. Furthermore, our data suggest that exogenous IL-10-induced decreases in BP in male SHRs are not dependent on upregulating renal NOS activity.
References: Am J Physiol Heart Circ Physiol. 2018 Dec 1;315(6):H1713-H1723. (PMID: 30239234)
Clin Exp Immunol. 1998 Jul;113(1):59-64. (PMID: 9697984)
Am J Physiol Renal Physiol. 2015 Apr 1;308(7):F706-12. (PMID: 25503730)
Hypertension. 2009 Sep;54(3):619-24. (PMID: 19620507)
Hypertens Pregnancy. 2015;34(3):291-306. (PMID: 25996051)
Circulation. 2015 Jan 27;131(4):e29-322. (PMID: 25520374)
Hypertension. 2020 Jun;75(6):1615-1623. (PMID: 32336228)
Am J Physiol Regul Integr Comp Physiol. 2012 Aug 15;303(4):R359-67. (PMID: 22761180)
JAMA. 2003 May 21;289(19):2560-72. (PMID: 12748199)
Life Sci. 2016 Jan 15;145:137-43. (PMID: 26682936)
Am J Hypertens. 2015 Jan;28(1):135-42. (PMID: 24906486)
J Cardiovasc Pharmacol. 1992;20 Suppl 12:S50-3. (PMID: 1282985)
J Exp Med. 2009 Aug 3;206(8):1755-67. (PMID: 19635862)
Hypertension. 2014 Sep;64(3):573-82. (PMID: 24935938)
Am J Physiol Regul Integr Comp Physiol. 2010 Jan;298(1):R61-9. (PMID: 19889864)
Cytokine. 2019 Jan;113:185-194. (PMID: 30539780)
J Biol Chem. 2003 Sep 26;278(39):37874-80. (PMID: 12857749)
Hypertension. 2014 Sep;64(3):557-64. (PMID: 24914200)
Am J Physiol Heart Circ Physiol. 2002 Aug;283(2):H658-63. (PMID: 12124213)
Gene Ther. 2009 Mar;16(3):383-91. (PMID: 18818668)
Hypertension. 2011 Mar;57(3):469-76. (PMID: 21263125)
معلومات مُعتمدة: R01 HL127091 United States HL NHLBI NIH HHS; R01 HL127091 United States GF NIH HHS
فهرسة مساهمة: Keywords: T cells; hypertension; nitric oxide synthase; spontaneously hypertensive rats
المشرفين على المادة: 0 (Receptors, Interleukin-10)
130068-27-8 (Interleukin-10)
EC 1.14.13.39 (Nitric Oxide Synthase)
تواريخ الأحداث: Date Created: 20200721 Date Completed: 20201127 Latest Revision: 20210903
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC7509288
DOI: 10.1152/ajprenal.00206.2020
PMID: 32686523
قاعدة البيانات: MEDLINE
الوصف
تدمد:1522-1466
DOI:10.1152/ajprenal.00206.2020